Dr. Scott Swanson is a Senior Surgeon and Director of the Minimally Invasive Thoracic Surgery (MITS) Program at Brigham and Women's Hospital in Boston, MA. As he has an extensive background in MITS, he is the Thoracic Oncology Disease Center Leader for the Dana-Farber Cancer Institute/Brigham and Women's Thoracic Oncology Program. As part of the Brigham and Women's Hospital Thoracic Surgery Program, Dr. Scott Swanson is involved with all aspects of lung disease including workup and treatment of advanced lung cancer and COPD.

Dr. Swanson chaired and published the results of the first cooperative cancer group protocol that examined the use of minimally invasive lobectomy for lung cancer (CALGB 39802, JCO Nov 2007). He is co-authoring The Atlas of Minimally Invasive Thoracic Surgery which will be available early in 2011 (Elsevier). Dr. Swanson's clinical focus is in the area of thoracic oncology including lung, esophageal and pleural malignancies as well as malignancies of the mediastinum including thymomas. His research will compliment the existing extensive divisional strength focused on the biology of thoracic malignancy. Also, he is currently co-investigating the role of micro-RNA in esophageal cancer. Also, Dr. Swanson directed the Second International Minimally Invasive Thoracic Surgery Summit that was held in Boston in October 2009.

Administratively, Dr. Swanson serves as the Chief Surgical Officer of the Dana-Farber Cancer Institute. Dr. Swanson received his M.D. from Harvard Medical School and completed his residency at Brigham & Women's Hospital.